These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23278726)

  • 1. 'Monster cell' melanoma with pulmonary metastasis and cyclin D1 amplification.
    Hawryluk EB; Baran JL; Gerami P; Sepehr A
    J Cutan Pathol; 2013 Jan; 40(1):61-5. PubMed ID: 23278726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
    Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
    Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
    [No Abstract]   [Full Text] [Related]  

  • 3. An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma.
    Ríos-Martín JJ; Pérez-Pérez M; Umbría-Jiménez S; Moreno-Ramírez D; Vallejo-Benítez A
    Int J Surg Pathol; 2022 May; 30(3):313-316. PubMed ID: 34541940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
    Gammon B; Ali L; Guitart J; Gerami P
    Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
    Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
    Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
    Nai G; Marques M
    Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma.
    Defty CL; Segen J; Carter JJ; Ahmed I; Carr RA
    J Cutan Pathol; 2011 Apr; 38(4):354-6. PubMed ID: 21039745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
    Utikal J; Udart M; Leiter U; Peter RU; Krähn G
    Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monster cells in malignant melanoma.
    Boyd AS; Wu H; Shyr Y
    Am J Dermatopathol; 2005 Jun; 27(3):208-10. PubMed ID: 15900123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
    Yamaura M; Takata M; Miyazaki A; Saida T
    Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas.
    Gerami P; Guitart J; Martini M; Wayne JD; Kuzel T
    Arch Dermatol; 2008 Sep; 144(9):1235-6. PubMed ID: 18794480
    [No Abstract]   [Full Text] [Related]  

  • 16. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.
    Burnworth B; Popp S; Stark HJ; Steinkraus V; Bröcker EB; Hartschuh W; Birek C; Boukamp P
    Oncogene; 2006 Jul; 25(32):4399-412. PubMed ID: 16547504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
    Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
    Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A silent-growing and fast-killing melanoma in a teenager].
    Uguen A; Talagas M; Quintin-Roué I; Abasq C; Coat C; Charles-Pétillon F; De Braekeleer M; Marcorelles P
    Ann Pathol; 2012 Aug; 32(4):254-8. PubMed ID: 23010398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24.
    Pouryazdanparast P; Cowen DP; Beilfuss BA; Haghighat Z; Guitart J; Rademaker A; Gerami P
    Am J Surg Pathol; 2012 Feb; 36(2):253-64. PubMed ID: 22020039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM; Straume O; Akslen LA
    Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.